Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fox

Showing results (1311-1320 of 1,511) with videos related to

Pageof 152
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 2, 2025
Modified titration of donanemab reduces ARIA risk and maintains amyloid reductionHong Wang, Emel Serap Monkul Nery, Paul Ardayfio, et al.
Neuroimage|March 24, 2015
Accelerated vs. unaccelerated serial MRI based TBM-SyN measurements for clinical trials in Alzheimer's diseasePrashanthi Vemuri, Matthew L Senjem, Jeffrey L Gunter, et al.
Human Molecular Genetics|July 3, 2015
Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPTTeresa Sposito, Elisavet Preza, Colin J Mahoney, et al.
Alzheimer'S Research & Therapy|April 29, 2020
Imaging biomarkers in neurodegeneration: current and future practicesPeter N E Young, Mar Estarellas, Emma Coomans, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 14, 2025
Inhibition of FOXM1 Synergizes with BH3 Mimetics Venetoclax and Sonrotoclax in Killing Multiple Myeloma Cells through Repressing MYC PathwayZhi Wen, Yidan Wang, Kathryn C Fox, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 12, 2025
Ultra-fast MRI for dementia diagnosis and treatment eligibility: A prospective studyMiguel Rosa-Grilo, Haroon R Chughtai, David L Thomas, et al.
The Lancet. Neurology|May 19, 2007
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx studyHoward H Feldman, Steven Ferris, Bengt Winblad, et al.
Neurology|September 2, 2016
Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementiaJonathan D Rohrer, Ione O C Woollacott, Katrina M Dick, et al.
Blood Advances|January 4, 2018
The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemiaLucy C Fox, Katherine D Cummins, Ben Costello, et al.
Journal of Neurology|June 26, 2020
Olfactory testing does not predict β-amyloid, MRI measures of neurodegeneration or vascular pathology in the British 1946 birth cohortSarah M Buchanan, Thomas D Parker, Christopher A Lane, et al.
Pageof 152

Showing results (1311-1320 of 1,511) with videos related to

Sort By:
Pageof 152
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 2, 2025
Modified titration of donanemab reduces ARIA risk and maintains amyloid reductionHong Wang, Emel Serap Monkul Nery, Paul Ardayfio, et al.
Neuroimage|March 24, 2015
Accelerated vs. unaccelerated serial MRI based TBM-SyN measurements for clinical trials in Alzheimer's diseasePrashanthi Vemuri, Matthew L Senjem, Jeffrey L Gunter, et al.
Human Molecular Genetics|July 3, 2015
Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPTTeresa Sposito, Elisavet Preza, Colin J Mahoney, et al.
Alzheimer'S Research & Therapy|April 29, 2020
Imaging biomarkers in neurodegeneration: current and future practicesPeter N E Young, Mar Estarellas, Emma Coomans, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 14, 2025
Inhibition of FOXM1 Synergizes with BH3 Mimetics Venetoclax and Sonrotoclax in Killing Multiple Myeloma Cells through Repressing MYC PathwayZhi Wen, Yidan Wang, Kathryn C Fox, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 12, 2025
Ultra-fast MRI for dementia diagnosis and treatment eligibility: A prospective studyMiguel Rosa-Grilo, Haroon R Chughtai, David L Thomas, et al.
The Lancet. Neurology|May 19, 2007
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx studyHoward H Feldman, Steven Ferris, Bengt Winblad, et al.
Neurology|September 2, 2016
Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementiaJonathan D Rohrer, Ione O C Woollacott, Katrina M Dick, et al.
Blood Advances|January 4, 2018
The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemiaLucy C Fox, Katherine D Cummins, Ben Costello, et al.
Journal of Neurology|June 26, 2020
Olfactory testing does not predict β-amyloid, MRI measures of neurodegeneration or vascular pathology in the British 1946 birth cohortSarah M Buchanan, Thomas D Parker, Christopher A Lane, et al.
Pageof 152